Elevated Levels of Platelet Activating Factor and Its Acetylhydrolase Indicate High Risk of Kawasaki Disease

被引:14
作者
Yi, Lunyu [1 ]
Zhang, Jing [2 ]
Zhong, Jiarong [1 ]
Zheng, Yuqiang [1 ]
机构
[1] Chongqing Med Univ, China Int Sci & Technol Cooperat Base Child Dev &, Natl Clin Res Ctr Child Hlth & Disorders,Chongqin, Minist Educ,Key Lab Child Dev & Disorders,Childre, Chongqing, Peoples R China
[2] China Japan Friendship Hosp, Dept Pediat, Beijing 100029, Peoples R China
关键词
Kawasaki disease; platelet activating factor; platelet activating factor acetylhydrolase; coronary artery lesion; LONG-TERM MANAGEMENT; INTRAVENOUS IMMUNOGLOBULIN; HEALTH-PROFESSIONALS; INFLAMMATION; RESISTANCE; STATEMENT; DIAGNOSIS; EVENTS; PAF;
D O I
10.1089/jir.2019.0141
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Kawasaki disease (KD) is a systemic vasculitis in children, which is related to inflammation and abnormal activation of immune system. Platelet activating factor (PAF) and its acetylhydrolase (PAF-AH) may play an important role in the pathogenesis of KD. This study aimed to investigate diagnosis and prognostic value of serum PAF and PAF-AH in KD. One hundred thirteen KD children were divided into coronary artery lesion (CAL) KD, noncoronary artery lesion (NCAL) KD, intravenous immunoglobulin (IVIG)-responsive KD, and IVIG-nonresponsive KD group. Seventy cases of fever control (F) group and 71 cases of normal control (N) group were set up. Peripheral venous blood was collected to detect serum PAF and PAF-AH levels, combined with other inflammatory mediators. Results showed that the serum levels of PAF and PAF-AH were significantly elevated in the KD group compared with F group and N group (P < 0.05). And the levels of conventional inflammatory mediators in KD group were significantly higher than those of F group (P < 0.05). In children with fever (KD group and F group), the area under the receiver operating characteristic curve (AUC) for PAF in prediction of KD was 0.804, and the estimated sensitivity and specificity were 79.6% and 74.3% with a cutoff of PAF >201.77 ng/mL, respectively; the AUC for PAF-AH in prediction of KD was 0.587, and the estimated sensitivity and specificity were 61.9% and 55.7% with a cutoff of PAF-AH >0.153 mu mol/min/mL, respectively. Compared with NCAL group, PAF and C-reactive protein were higher in CAL group (P < 0.05). The AUC for PAF in prediction of CAL KD was 0.679, and the estimated sensitivity and specificity were 96.0% and 40.9% with a cutoff of PAF >225.52 ng/mL, respectively. Thus, serum levels of PAF and PAF-AH were significantly elevated in the acute phase of KD. Serum PAF and PAF-AH contributed to the diagnosis of KD, and serum PAF has a greater diagnostic value for KD. At the same time, elevated serum PAF has a certain predictive value for the occurrence of coronary artery lesions in Kawasaki disease rather than IVIG-nonresponsive KD.
引用
收藏
页码:159 / 167
页数:9
相关论文
共 36 条
[1]   Pathophysiological Alterations of Redox Signaling and Endocannabinoid System in Granulocytes and Plasma of Psoriatic Patients [J].
Ambrozewicz, Ewa ;
Wojcik, Piotr ;
Wronski, Adam ;
Luczaj, Wojciech ;
Jastrzab, Anna ;
Zarkovic, Neven ;
Skrzydlewska, Elzbieta .
CELLS, 2018, 7 (10)
[2]   Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition) [J].
Ayusawa, M ;
Sonobe, T ;
Uemura, S ;
Ogawa, S ;
Nakamura, Y ;
Kiyosawa, N ;
Ishii, M ;
Harada, K .
PEDIATRICS INTERNATIONAL, 2005, 47 (02) :232-234
[3]   Adjunctive therapies for Kawasaki disease [J].
Campbell, Anita J. ;
Burns, Jane C. .
JOURNAL OF INFECTION, 2016, 72 :S1-S5
[4]   Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF [J].
Chaithra, Vyala Hanumanthareddy ;
Jacob, Shancy Petsel ;
Lakshmikanth, Chikkamenahalli Lakshminarayana ;
Sumanth, Mosale Seetharam ;
Abhilasha, Kandahalli Venkataranganayaka ;
Chen, Chu-Huang ;
Thyagarajan, Anita ;
Sahu, Ravi P. ;
Travers, Jeffery Bryant ;
McIntyre, Thomas M. ;
Kemparaju, Kempaiah ;
Marathe, Gopal Kedihithlu .
JOURNAL OF LIPID RESEARCH, 2018, 59 (11) :2063-2074
[5]   Pathogenetic determinants in Kawasaki disease: the haematological point of view [J].
Del Principe, Domenico ;
Pietraforte, Donatella ;
Gambardella, Lucrezia ;
Marchesi, Alessandra ;
de Jacobis, Isabella Tarissi ;
Villani, Alberto ;
Malorni, Walter ;
Straface, Elisabetta .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2017, 21 (04) :632-639
[6]   Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin [J].
Galeotti, Caroline ;
Bayry, Jagedeesh ;
Kone-Paut, Isabelle ;
Kaveri, Srinivas V. .
AUTOIMMUNITY REVIEWS, 2010, 9 (06) :441-448
[7]   Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis [J].
Gill, Parwinder ;
Jindal, Nina Lakhani ;
Jagdis, Amanda ;
Vadas, Peter .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (06) :1424-1432
[8]   Cytokine modulation with immune γ-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment [J].
Gupta, M ;
Noel, GJ ;
Schaefer, M ;
Friedman, D ;
Bussel, J ;
Johann-Liang, R .
JOURNAL OF CLINICAL IMMUNOLOGY, 2001, 21 (03) :193-199
[9]  
Hassan Mohamed, 2015, Glob Cardiol Sci Pract, V2015, P6, DOI 10.5339/gcsp.2015.6
[10]   Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model [J].
Henderson, WR ;
Lu, JY ;
Poole, KM ;
Dietsch, GN ;
Chi, EY .
JOURNAL OF IMMUNOLOGY, 2000, 164 (06) :3360-3367